original ) (raw )The results of therapy in patients with high-risk neuroblastoma: the experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
Alexey Nechesnyuk
Pediatric Hematology/Oncology and Immunopathology
View PDFchevron_right
Individualized therapy in neuroblastoma
Thorsten Simon
Russian Journal of Children Hematology and Oncology
View PDFchevron_right
Pseudoprogression in a patient with relapsed medulloblastoma after intensive chemotherapy and craniospinal irradiation. A clinical observation and literature review
O. Zheludkova
Russian Journal of Pediatric Hematology and Oncology, 2020
View PDFchevron_right
High-dose chemotherapy with autologous hematopoietic stem cell transplantation in high-risk neuroblastoma patients: Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, First Pavlov State Medical University of St. Petersburg experience
L. Zubarovskaya
Russian Journal of Children Hematology and Oncology, 2019
View PDFchevron_right
Clinical case of five-year local control following radiosurgery of intracranial tumors in a patient with type II neurofibromatosis
Oksana Zemskova
Ukrainian Neurosurgical Journal
View PDFchevron_right
Immunotherapy by anti-GD2 antibodies in patients with primary high-risk neuroblastoma, primary resistant and relapsed disease: Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, First Pavlov State Medical University of St. Petersburg experience
L. Zubarovskaya
Russian Journal of Pediatric Hematology and Oncology, 2021
View PDFchevron_right
Repeated Craniospinal Irradiation in Patients with Recurrence of Medulloblastoma
Andrey Golanov
2020
View PDFchevron_right
Affective comorbidities in diseases of the nervous-muscular system: a crosssectional observation study in the Republic of Bashkortostan, Russia
West Kazakhstan Medical Journal
View PDFchevron_right
Personalization of the use of non-steroidal anti-inflammatory drugs for musculoskeletal diseases. Resolution on the results of the Meeting of Experts of December 13, 2017
Sergey Mazurenko
Medical Council
View PDFchevron_right
Effect of MSCS on Cisplatin Toxicity in Neuroblastoma Model
Blaženka Miškić
Science Azerbaycan, 2021
View PDFchevron_right
MRI diagnosis of spinal metastasis of medulloblastoma. A clinical case and literature review
Sergey Ozerov
Voprosy neirokhirurgii imeni N.N. Burdenko, 2015
View PDFchevron_right
[Endocrine late-effects and bone mineral density after combined treatment of malignant brain tumors in childhood and adolescence]
O. Zheludkova
Problemy endokrinologii, 2021
View PDFchevron_right
Subsequent gliomas in survivors of paediatric neoplasms
Sergey Ozerov
Pediatric Hematology/Oncology and Immunopathology, 2018
View PDFchevron_right
Individual peculiarities in pharmacokinetics of antiblastomic drugs in healthy volunteers
Rodion Oseshnyuk
Reviews on Clinical Pharmacology and Drug Therapy, 2017
View PDFchevron_right
Atypical and typical course of neurofibromatosis type 1 in combination with pheochromocytoma
Nurana Nuralieva
Endocrine Surgery
View PDFchevron_right
Atypical hemolytic uremic syndrome in high-risk neuroblastoma patient: case report
M. Belogurova
2021
View PDFchevron_right
Formation of beneficial and pathological neuroplasticity depending on the nature of the prognosis in different types of the course in patients with sporadic and familial forms of multiple sclerosis
Ivan Voloshyn-Gaponov
Ukrains'kyi Visnyk Psykhonevrolohii
View PDFchevron_right
Clinical and molecular characteristics of WNT medulloblastomas
Alexey Nechesnyuk
Pediatric Hematology/Oncology and Immunopathology, 2019
View PDFchevron_right
Multiple Myeloma of the Spine: Survival, Complications, and Neurological Status After Surgical Treatment
Nikita Zaborovskii
Traumatology and Orthopedics of Russia, 2016
View PDFchevron_right
Current state of antiangiogenic therapy in neuro-oncology and own experience of its use in the radiosurgical treatment of recurrent glioblastoma
Abbas Abbas
Ukrainian Neurosurgical Journal, 2021
View PDFchevron_right
Neurofibromatosis: analysis of clinical cases and new diagnostic criteria
Andrey Golanov
Neuromuscular Diseases, 2022
View PDFchevron_right
Peri-Operative Chemotherapy in Muscle Invasive Bladder Cancer: Overview and a Rationale for the Need to Seek Alternative Treatment: Magnolia Clinical Trial
Wim Witjes
DOAJ (DOAJ: Directory of Open Access Journals), 2014
View PDFchevron_right
Prognostic markers of efficiency of immunosupressive therapy in patients with myelodysplastic syndrome
Мар'яна Сімонова
ScienceRise, 2015
View PDFchevron_right
Experience of Application of Magnetic Resonance Myelography Methods in Patients with Neurological and Neurosurgical Pathology
A. Tulupov
Radiology - Practice, 2021
View PDFchevron_right
Symptoms following TKI therapy discontinuation after achieving an adequate response in patients with chronic myeloid leukemia in chronic phase (CML-CP)
Annie Guerin
Journal of Clinical Oncology
View PDFchevron_right
Modern approaches to vestibular schwannomas treatment in patients with neurofibromatosis type 2 using stereotactic radiosurgery
Oksana Zemskova
Ukrainian Neurosurgical Journal, 2014
View PDFchevron_right
Tumor-induced osteomalacia: a clinical case report
Константин Слащук
Osteoporosis and Bone Diseases, 2019
View PDFchevron_right
Methodology and experience in studying the psychosocial aspects of the surgical treatment of patients with musculoskeletal bone tumors
Galina Isurina
Vestnik of Saint Petersburg University. Psychology
View PDFchevron_right
Pseudoprogression in a Patient with Anaplastic Ependymoma After Radiation Therapy
O. Zheludkova
Medical Visualization
View PDFchevron_right
Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies
Vicent Balanzá-Martínez
Psychotherapy and Psychosomatics, 2014
View PDFchevron_right
Brachytherapy for retinoblastoma: a 13 year experience
Andrey Golanov
Malignant tumours, 2021
View PDFchevron_right
The role of denosumab in the complex treatment of giant cell tumor of the spine: reducing of local recurrence rate, surgery time and blood loss
Kirill Borzov
Hirurgiâ pozvonočnika (Spine Surgery), 2021
View PDFchevron_right
Neutropenia induced by non-cytotoxic drugs
Slobodan Jankovic
Racionalna terapija, 2016
View PDFchevron_right
Результаты лечения редких эмбриональных опухолей ЦНС у детей
Sergey Gorelyshev
Педиатрия. Журнал им. Г. Н. Сперанского, 2008
View PDFchevron_right
The changes of standard DXA measurements and TBS depending on outcomes of neurosurgical treatment in patients with Cushing's disease
Alexander Solodovnikov
Osteoporosis and Bone Diseases, 2019
View PDFchevron_right